Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
17 Results for "
SMYD2
" in MedChemExpress (MCE) Product Catalog:
Products (17)
17 Results for "SMYD2" in MCE Product Catalog:
22
22 Publications Verification
Target:
Research Areas:
AZ505 is a potent and selective SMYD2 inhibitor with an IC50 of 0.12 μM.
22
22 Publications Verification
Target:
Research Areas:
AZ505 ditrifluoroacetate is a potent and selective SMYD2 inhibitor with IC50 of 0.12 μM.
11
11 Cited Publications
Cat. No.: HY-19313
CAS No.: 1793053-37-8
Target:
Research Areas:
LLY-507 is a potent and selective inhibitor of protein-lysine methyltransferase SMYD2. LLY-507 potently inhibits the ability of SMYD2 to methylate p53 peptide with an IC50 <15 nM. LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes .
7
7 Cited Publications
Cat. No.: HY-19546
CAS No.: 1906919-67-2
Target:
Research Areas:
BAY-598, a chemical probe, is selective small molecule inhibitor of SMYD2 with an IC50 of 27 nM [2].
2
2 Cited Publications
Target:
Research Areas:
AZ506 is a potent SMYD2 inhibitor with an IC50 of 17 nM. AZ506 inhibits SMYD2 methyltransferase activity in cells, leading to a decrease in the SMYD2-mediated methylation signal .
1
1 Cited Publications
Cat. No.: HY-P76079
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: N-lysine methyltransferase SMYD2; HSKM-B; Lysine N-methyltransferase 3C; SMYD2; KMT3C
Species:
Source:
Cat. No.: HY-19563
CAS No.: 1868232-32-9
Target:
Research Areas:
A-893 is a cell-active inhibitor of Methyltransferase SMYD2, with an IC50 of 2.8 nM.
Cat. No.: HY-111367
CAS No.: 2587612-25-5
Research Areas:
MS2734 is a dual-substrate NNMT inhibitor that acts as a SAM (HY-B0617) competitor and a non-competitor of Nicotinamide (HY-B0150), with an IC50 of 14 μM and a Kd of 2.7 μM against hNNMT. MS2734 inhibits the methyltransferase activities of DOT1L (IC50 1.3 μM), PRMT7 (IC50 20 μM), BCDIN3D (IC50 40 μM) and SMYD2 (IC50 62 μM). MS2734 is applicable to research related to diabetes, obesity and various cancers [2] .
Cat. No.: HY-RS13462
Target:
Research Areas:
SMYD2 Human Pre-designed siRNA Set A contains three designed siRNAs for SMYD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS13463
Target:
Research Areas:
Smyd2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Smyd2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS13464
Target:
Research Areas:
Smyd2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Smyd2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-111810
CAS No.: 2023788-96-5
Target:
Research Areas:
SMYD2-IN-1 is a SMYD2 inhibitor extracted from patent WO2016166186A1, compound example 1.1, has an IC50 of 4.45 nM .
Cat. No.: HY-169113
CAS No.: 1887193-58-9
Target:
Research Areas:
EPZ032597 is a selective and noncompetitive SMYD2 inhibitor with an IC50 value of 16 nM. EPZ032597 is promising for research of pancreatic ductal adenocarcinoma [2].
Cat. No.: HY-19546A
CAS No.: 1906920-28-2
Target:
Research Areas:
(R)-BAY-598 ((R)-4) is a potent inhibitor of protein-lysine methyltransferase SMYD2, with the IC50 of 1.7 μM .
Cat. No.: HY-164144
CAS No.: 1887195-17-6
Target:
Research Areas:
EPZ033294 is an inhibitor of SYMD2 (IC50 is 3.9 nM). SYMD2 itself has catalytic activity and can methylate the lysine residue of BTF3 to BTF3me1, which was experimentally demonstrated by detecting an IC50 of 2.9 nM for inhibition of BTF3ME1 by SYMD2, indicating an active inhibition of SYMD2 by EPZ033294. EPZ033294 (0-50 µM) has an inhibitory effect on SYMD2 and a concentration-dependent inhibitory effect in 293T .
Cat. No.: HY-P85491
Synonyms: Histone methyltransferase SMYD2; HSKM B; HSKM-B; HSKMB; KMT3C; Lysine N-methyltransferase 3C; MGC119305; N lysine methyltransferase SMYD2; N-lysine methyltransferase SMYD2; SET and MYND domain containing 2; SET and MYND domain containing protein 2; SET and MYND domain-containing protein 2; SMYD2; SMYD2_HUMAN; Zinc finger MYND domain containing 14; ZMYND14.
Cat. No.: HY-186163
CAS No.: 636564-27-7
Target:
Research Areas:
CC-410 is a selective Nicotinamide N-methyltransferase (NNMT) inhibitor with a human IC50 value of 1.6 µM. CC-410 impairs terminal adipocyte differentiation via glucocorticoid signaling network deregulation, inhibits adipogenesis and lipid accumulation with time-sensitive activity limited to early adipogenesis stages. CC-410 can be used for the researches of early-onset obesity, glucocorticoid-induced obesity .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
